These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23072840)

  • 21. Relationships between immunophenotype, Ki-67 index, microvascular density, Ep-CAM/P-cadherin, and MMP-2 expression in early-stage invasive ductal breast cancer.
    Niemiec JA; Adamczyk A; Małecki K; Majchrzyk K; Ryś J
    Appl Immunohistochem Mol Morphol; 2012 Dec; 20(6):550-60. PubMed ID: 22531681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of cell adhesion molecules and prognosis in breast cancer.
    Saadatmand S; de Kruijf EM; Sajet A; Dekker-Ensink NG; van Nes JG; Putter H; Smit VT; van de Velde CJ; Liefers GJ; Kuppen PJ
    Br J Surg; 2013 Jan; 100(2):252-60. PubMed ID: 23175431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nuclear and cytoplasmic accumulation of Ep-ICD is frequently detected in human epithelial cancers.
    Ralhan R; He HC; So AK; Tripathi SC; Kumar M; Hasan MR; Kaur J; Kashat L; MacMillan C; Chauhan SS; Freeman JL; Walfish PG
    PLoS One; 2010 Nov; 5(11):e14130. PubMed ID: 21152431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive value of E-cadherin and Ep-CAM in cervical lymph node metastasis of supraglottic larynx carcinoma.
    Ali Bayram ; Yüce İ; Çağlı S; Canöz Ö; Güney E
    Am J Otolaryngol; 2015; 36(6):736-40. PubMed ID: 26545462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subcellular differential expression of Ep-ICD in oral dysplasia and cancer is associated with disease progression and prognosis.
    Somasundaram RT; Kaur J; Leong I; MacMillan C; Witterick IJ; Walfish PG; Ralhan R
    BMC Cancer; 2016 Jul; 16():486. PubMed ID: 27421772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of membranous Ep-CAM in budding colorectal carcinoma cells.
    Gosens MJ; van Kempen LC; van de Velde CJ; van Krieken JH; Nagtegaal ID
    Mod Pathol; 2007 Feb; 20(2):221-32. PubMed ID: 17361206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of Ep-CAM in intestinal metaplasia, gastric epithelial dysplasia and gastric adenocarcinoma.
    Joo M; Kim H; Kim MK; Yu HJ; Kim JP
    J Gastroenterol Hepatol; 2005 Jul; 20(7):1039-45. PubMed ID: 15955212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytoplasmic tail regulates the intercellular adhesion function of the epithelial cell adhesion molecule.
    Balzar M; Bakker HA; Briaire-de-Bruijn IH; Fleuren GJ; Warnaar SO; Litvinov SV
    Mol Cell Biol; 1998 Aug; 18(8):4833-43. PubMed ID: 9671492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of COX-2 and Ep-CAM overexpression in human invasive breast cancer and its impact on survival.
    Spizzo G; Gastl G; Wolf D; Gunsilius E; Steurer M; Fong D; Amberger A; Margreiter R; Obrist P
    Br J Cancer; 2003 Feb; 88(4):574-8. PubMed ID: 12592372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epithelial cell adhesion molecule expression in pituitary adenomas: an immunohistochemical study.
    Ortiz-Plata A; Moreno-Leyva K; López-Gómez M; Santos-Salinas S; Sánchez-García A; Tena-Suck ML
    Ann Diagn Pathol; 2010 Dec; 14(6):418-24. PubMed ID: 21074690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue.
    Hein S; Müller V; Köhler N; Wikman H; Krenkel S; Streichert T; Schweizer M; Riethdorf S; Assmann V; Ihnen M; Beck K; Issa R; Jänicke F; Pantel K; Milde-Langosch K
    Breast Cancer Res Treat; 2011 Sep; 129(2):347-60. PubMed ID: 20972617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EpCAM nuclear localization identifies aggressive thyroid cancer and is a marker for poor prognosis.
    Ralhan R; Cao J; Lim T; Macmillan C; Freeman JL; Walfish PG
    BMC Cancer; 2010 Jun; 10():331. PubMed ID: 20579375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A shift from membranous and stromal syndecan-1 (CD138) expression to cytoplasmic CD138 expression is associated with poor prognosis in breast cancer.
    Kind S; Jaretzke A; Büscheck F; Möller K; Dum D; Höflmayer D; Hinsch A; Weidemann S; Fraune C; Möller-Koop C; Hube-Magg C; Simon R; Wilczak W; Lebok P; Witzel I; Müller V; Schmalfeldt B; Paluchowski P; Wilke C; Heilenkötter U; von Leffern I; Krech T; Krech RH; von der Assen A; Bawahab AA; Burandt E
    Mol Carcinog; 2019 Dec; 58(12):2306-2315. PubMed ID: 31545001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expressions of Ep-CAM and cyclin D1 and their clinical significance in gallbladder carcinoma].
    Ren G; Yu G; Liu LW; Ma L
    Zhonghua Zhong Liu Za Zhi; 2009 Nov; 31(11):841-4. PubMed ID: 20137349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of nuclear hepatoma-derived growth factor (HDGF) localization in patients with breast cancer.
    Chen X; Yun J; Fei F; Yi J; Tian R; Li S; Gan X
    Pathol Res Pract; 2012 Aug; 208(8):437-43. PubMed ID: 22682760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers.
    Went P; Vasei M; Bubendorf L; Terracciano L; Tornillo L; Riede U; Kononen J; Simon R; Sauter G; Baeuerle PA
    Br J Cancer; 2006 Jan; 94(1):128-35. PubMed ID: 16404366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of S100A4-expression and subcellular localization in early-stage breast cancer.
    Egeland EV; Boye K; Park D; Synnestvedt M; Sauer T; ; Naume B; Borgen E; Mælandsmo GM
    Breast Cancer Res Treat; 2017 Feb; 162(1):127-137. PubMed ID: 28058579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathologic Characteristics of Trop Family Proteins (Trop-2 and EpCAM) in Gastric Carcinoma.
    Kim HS; Kim Y; Lee HS
    J Gastric Cancer; 2024 Oct; 24(4):391-405. PubMed ID: 39375055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fatty acid binding protein 7 expression and its sub-cellular localization in breast cancer.
    Alshareeda AT; Rakha EA; Nolan CC; Ellis IO; Green AR
    Breast Cancer Res Treat; 2012 Jul; 134(2):519-29. PubMed ID: 22562177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific targeting of Ep-CAM in various carcinomas by novel monoclonal antibodies.
    Sithambaram D; Palanivelu S; Subramanian K; Sahoo S; Verma RS
    Hybridoma (Larchmt); 2011 Dec; 30(6):511-8. PubMed ID: 22149275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.